BioCryst Pharmaceuticals BCRX Lease Liability Payments - Due Year Two
Lease Liability Payments - Due Year Two at other companies
Other financials
Where this comes from
Reported directly by BioCryst Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:FinanceLeaseLiabilityPaymentsDueYearTwo.
The official record: BioCryst Pharmaceuticals’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about BioCryst Pharmaceuticals's lease liability payments - due year two.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is BioCryst Pharmaceuticals's lease liability payments - due year two?
- BioCryst Pharmaceuticals (BCRX) reported lease liability payments - due year two of $486K in Q1 2026.
- How has BioCryst Pharmaceuticals's lease liability payments - due year two changed year-over-year?
- BioCryst Pharmaceuticals's lease liability payments - due year two decreased by 52.2% year-over-year, from $1.02M to $486K.
- What does lease liability payments - due year two mean?
- This metric identifies the total cash payments required for operating and finance leases in the second year following the current balance sheet date. It helps investors forecast long-term fixed cost commitments and cash flow requirements. It is essential for modeling the company's future solvency and operational leverage.